# Crane Co: overview

CR · NYSE · CIK 1944013 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cr.md) · [Financials](/companies/cr/financials.md) · [Filings](/companies/cr/filings.md) · [Insiders](/companies/cr/insiders.md)

Latest reported revenue: [$754.6m](/filings/0001628280-26-068180.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:Revenues, accession 0001628280-26-068180).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [544](/filings/0001628280-25-008728.md) | [558](/filings/0001944013-26-000161.md) | [577](/filings/0001944013-26-000186.md) | [589](/filings/0001628280-26-068180.md) | [581 d](/filings/0001944013-26-000095.md) | [696](/filings/0001944013-26-000161.md) | [725](/filings/0001944013-26-000186.md) | [755](/filings/0001628280-26-068180.md) |
| Gross margin | % | [40.9%](/filings/0001628280-25-008728.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [15.8%](/filings/0001628280-25-008728.md) | [18.1%](/filings/0001944013-26-000161.md) | [17.8%](/filings/0001944013-26-000186.md) | [20.1%](/filings/0001628280-26-068180.md) | [17.5% d](/filings/0001944013-26-000095.md) | [14.4%](/filings/0001944013-26-000161.md) | [19.9%](/filings/0001944013-26-000186.md) | [18.6%](/filings/0001628280-26-068180.md) |
| Net margin | % | [14.9%](/filings/0001628280-25-008728.md) | [19.2%](/filings/0001944013-26-000161.md) | [15.0%](/filings/0001944013-26-000186.md) | [15.5%](/filings/0001628280-26-068180.md) | [14.1% d](/filings/0001944013-26-000095.md) | [9.6%](/filings/0001944013-26-000161.md) | [13.2%](/filings/0001944013-26-000186.md) | [12.9%](/filings/0001628280-26-068180.md) |
| Diluted EPS | $ per share | [1.38](/filings/0001628280-25-008728.md) | [1.83](/filings/0001944013-26-000161.md) | [1.47](/filings/0001944013-26-000186.md) | [1.56](/filings/0001628280-26-068180.md) | not reported | [1.14](/filings/0001944013-26-000161.md) | [1.63](/filings/0001944013-26-000186.md) | [1.66](/filings/0001628280-26-068180.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,063](/filings/0001628280-24-006915.md) | [1,777](/filings/0001628280-25-008728.md) | [1,862](/filings/0001944013-26-000095.md) | [2,131](/filings/0001944013-26-000095.md) | [2,305](/filings/0001944013-26-000095.md) |
| Gross margin | % | not reported | not reported | [40.3%](/filings/0001628280-25-008728.md) | [40.7%](/filings/0001628280-25-008728.md) | not reported |
| Operating margin | % | [10.7%](/filings/0001628280-24-006915.md) | [0.3%](/filings/0001628280-25-008728.md) | [13.4%](/filings/0001944013-26-000095.md) | [16.7%](/filings/0001944013-26-000095.md) | [18.4%](/filings/0001944013-26-000095.md) |
| Net margin | % | [21.1%](/filings/0001628280-24-006915.md) | [22.6%](/filings/0001628280-25-008728.md) | [13.7%](/filings/0001944013-26-000095.md) | [13.8%](/filings/0001944013-26-000095.md) | [15.9%](/filings/0001944013-26-000095.md) |
| Diluted EPS | $ per share | [7.36](/filings/0001628280-24-006915.md) | [7.01](/filings/0001628280-25-008728.md) | [4.45](/filings/0001944013-26-000095.md) | [5.05](/filings/0001944013-26-000095.md) | [6.26](/filings/0001944013-26-000095.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Gross profit: us-gaap:GrossProfit.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cr/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.13bn | 5,051,428 |  | Added +240,465 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $556.5m | 2,494,809 |  | Added +105,870 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $519.0m | 2,326,456 |  | Added +237,196 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $494.7m | 2,217,663 |  | Added +18,926 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $465.2m | 2,085,464 |  | Reduced −15,744 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $345.1m | 1,546,854 |  | Added +60,774 |
| [VICTORY CAPITAL MANAGEMENT INC](/funds/1040188.md) | 2026-06-30 | $295.7m | 1,325,800 |  | Added +1,317,063 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $291.8m | 1,315,151 |  | Added +336,116 |
| [Capital International Investors](/funds/1562230.md) | 2026-06-30 | $235.3m | 1,054,650 |  | Reduced −19,090 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $231.7m | 1,038,496 |  | New +1,038,496 |

## Recent filings

[All 294 filings](/companies/cr/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 15:30 ET | [10-Q](/filings/0001628280-26-068180.md) | Quarterly report, period 2026-09-30 | 0001628280-26-068180 |
| 2026-10-27 | 16:29 ET | [8-K](/filings/0001628280-26-067607.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-067607 |
| 2026-09-29 | 16:59 ET | [8-K](/filings/0001628280-26-063845.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-063845 |
| 2026-09-14 | 12:14 ET | [8-K](/filings/0001628280-26-061780.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-061780 |
| 2026-07-31 | 14:56 ET | [10-Q](/filings/0001944013-26-000186.md) | Quarterly report, period 2026-06-30 | 0001944013-26-000186 |
| 2026-07-28 | 16:28 ET | [8-K](/filings/0001944013-26-000181.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001944013-26-000181 |
| 2026-04-30 | 15:51 ET | [10-Q](/filings/0001944013-26-000161.md) | Quarterly report, period 2026-03-31 | 0001944013-26-000161 |
| 2026-04-27 | 17:19 ET | [8-K](/filings/0001944013-26-000133.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001944013-26-000133 |
| 2026-04-27 | 17:06 ET | [8-K](/filings/0001944013-26-000130.md) | 5.07 Shareholder vote results | 0001944013-26-000130 |
| 2026-04-27 | 16:34 ET | [8-K](/filings/0001944013-26-000125.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001944013-26-000125 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001944013-26-000095.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/9c3218de-3e17-48f0-bcaa-f63f7b0218f1)

## About the filer

- CIK: 1944013
- Tickers: CR
- Exchange: NYSE
- SIC code: 3490 Miscellaneous Fabricated Metal Products
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 15:36 ET. No prices; not investment advice.